Reuters Asia

India’s Eris Lifesciences to buy some dermatology brands from Glenmark Pharma

BENGALURU (Reuters) -Indian drugmaker Eris Lifesciences Ltd said on Tuesday it would acquire a portfolio of dermatology brands from Glenmark Pharmaceuticals Ltd for 3.4 billion rupees ($41.63 million) to deepen its presence in the anti-fungal and anti-psoriasis segments. The deal, through Eris’ dermatology focused unit, is for the purchase of nine brands, including Onabet, Halobate, …

India’s Eris Lifesciences to buy some dermatology brands from Glenmark Pharma Read More »

U.S., Taiwan officials pledge ambitious trade negotiating schedule

By David Lawder WASHINGTON (Reuters) – The United States and Taiwan concluded four days of trade negotiations on Monday and reached consensus on a number of areas related to trade facilitation, anti-corruption, small and medium-sized enterprises and regulatory practices, the U.S. Trade Representative’s office said. The first major negotiating round of the U.S.-Taiwan Initiative on …

U.S., Taiwan officials pledge ambitious trade negotiating schedule Read More »

China’s first population drop in six decades sounds alarm on demographic crisis

By Albee Zhang and Farah Master BEIJING/HONG KONG (Reuters) – China’s population fell last year for the first time in six decades, a historic turn that is expected to mark the start of a long period of decline in its citizen numbers with profound implications for its economy and the world. The country’s National Bureau …

China’s first population drop in six decades sounds alarm on demographic crisis Read More »

Japan yields top BOJ cap for third day on eve of crucial policy decision

By Kevin Buckland TOKYO (Reuters) – Japanese 10-year government bond yields topped the Bank of Japan’s (BOJ) policy ceiling for a third straight session on Tuesday amid swirling speculation that policymakers could tweak stimulus settings when a two-day meeting wraps up on Wednesday. The 10-year JGB yield rose 0.5 basis point to 0.505% as of …

Japan yields top BOJ cap for third day on eve of crucial policy decision Read More »